CN1477965A - 用于肿瘤治疗和诊断的药物制品及制备血浆无脂质部分的方法 - Google Patents

用于肿瘤治疗和诊断的药物制品及制备血浆无脂质部分的方法 Download PDF

Info

Publication number
CN1477965A
CN1477965A CNA018139744A CN01813974A CN1477965A CN 1477965 A CN1477965 A CN 1477965A CN A018139744 A CNA018139744 A CN A018139744A CN 01813974 A CN01813974 A CN 01813974A CN 1477965 A CN1477965 A CN 1477965A
Authority
CN
China
Prior art keywords
tumor
pharmaceutical preparation
blood
plasma
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018139744A
Other languages
English (en)
Chinese (zh)
Inventor
��ʲ
安德拉什·贝尔塔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1477965A publication Critical patent/CN1477965A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CNA018139744A 2000-07-10 2001-07-10 用于肿瘤治疗和诊断的药物制品及制备血浆无脂质部分的方法 Pending CN1477965A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0002597A HUP0002597A2 (hu) 2000-07-10 2000-07-10 Gyógyászati készítmény, elsősorban tumoros megbetegedések gyógyítására és diagnosztizálására és eljárás vérplazma lipidmentes frakciójának előállítására
HUP0002597 2000-07-10

Publications (1)

Publication Number Publication Date
CN1477965A true CN1477965A (zh) 2004-02-25

Family

ID=89978459

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA018139744A Pending CN1477965A (zh) 2000-07-10 2001-07-10 用于肿瘤治疗和诊断的药物制品及制备血浆无脂质部分的方法

Country Status (19)

Country Link
US (1) US20040253317A1 (enExample)
EP (1) EP1333844A2 (enExample)
JP (1) JP2004504353A (enExample)
KR (1) KR20030016392A (enExample)
CN (1) CN1477965A (enExample)
AU (1) AU2001277630A1 (enExample)
BG (1) BG107547A (enExample)
BR (1) BR0112866A2 (enExample)
CA (1) CA2415862A1 (enExample)
EA (1) EA005415B1 (enExample)
HR (1) HRP20030098A2 (enExample)
HU (1) HUP0002597A2 (enExample)
IL (1) IL153867A0 (enExample)
MX (1) MXPA03000342A (enExample)
PL (1) PL361049A1 (enExample)
SK (1) SK1282003A3 (enExample)
WO (1) WO2002007739A2 (enExample)
YU (1) YU9903A (enExample)
ZA (1) ZA200300675B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200172A2 (hu) 2002-01-15 2003-11-28 András Bertha Eljárás tumorellenes hatóanyag kinyerésére
GB2405540B (en) * 2003-08-27 2006-05-10 Ron Shu-Yuen Hui Apparatus and method for providing dimming control of lamps and electrical lighting systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB791142A (en) * 1954-09-22 1958-02-26 Atsuwo Ushiyama A process for preparing antibiotic substance from special bacterium in human blood plasma and earth
GB834256A (en) * 1955-08-18 1960-05-04 Olin Mathieson Therapeutic bone mixture
US3083194A (en) * 1959-05-18 1963-03-26 Thies Karl Montmorillonite adsorption of fibrin from bovine blood plasma
JPS5357191A (en) * 1976-11-04 1978-05-24 Asahi Chem Ind Co Ltd Activated carbon for adsorption of toxin in serum
NL9001087A (nl) * 1990-05-07 1991-12-02 Harimex Ligos Bv Werkwijze voor het zuiveren van bloedplasma.
RO111332B1 (ro) * 1991-06-17 1996-09-30 Inst De Cercetari Chimico Farm Procedeu de obținere a unui produs hepatoprotector
HUP9900045A3 (en) * 1999-01-08 2001-02-28 Martyn Robertne Goeroeg Jolan Improved leukaemic blood-based product and their use in therapy

Also Published As

Publication number Publication date
EA005415B1 (ru) 2005-02-24
BR0112866A2 (enExample) 2009-12-08
CA2415862A1 (en) 2002-01-31
WO2002007739A9 (en) 2003-10-16
PL361049A1 (en) 2004-09-20
JP2004504353A (ja) 2004-02-12
HUP0002597A2 (hu) 2003-01-28
WO2002007739A2 (en) 2002-01-31
KR20030016392A (ko) 2003-02-26
HU0002597D0 (en) 2000-09-28
HRP20030098A2 (en) 2004-08-31
SK1282003A3 (en) 2003-08-05
ZA200300675B (en) 2004-02-19
MXPA03000342A (es) 2004-12-13
YU9903A (sh) 2006-05-25
WO2002007739A3 (en) 2002-10-10
EP1333844A2 (en) 2003-08-13
EA200300133A1 (ru) 2003-06-26
US20040253317A1 (en) 2004-12-16
BG107547A (bg) 2004-01-30
AU2001277630A1 (en) 2002-02-05
IL153867A0 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
CN1245993C (zh) 用于治疗肿瘤的含有鲨鱼软骨提取物和抗肿瘤剂的药物组合物
CN1290862C (zh) 一种脾多肽提取物、其制备方法及其用途
CN1031184A (zh) 药用组合物及其制备和应用
CN1901925A (zh) 包括不同类型转移因子的组合物,制备该组合物的方法,以及使用该组合物的治疗方法
CN1477965A (zh) 用于肿瘤治疗和诊断的药物制品及制备血浆无脂质部分的方法
CN1424057A (zh) 一种中药免疫调节剂及其制法和在制药中的应用
CN1291105A (zh) 半抗原修饰的肿瘤细胞膜和制备及应用半抗原修饰的肿瘤细胞膜的方法
CN1171630C (zh) 从香菇菌丝体的提取物来源的lak活性增强剂和含有此提取物的lak活性增强配方
CN1199653C (zh) 罗勒多糖在制备治疗抗肿瘤转移的药品中的应用
CN114222814B (zh) 具有比人外周血的自然杀伤细胞更高水平的自然细胞毒性受体、杀伤活性及γ-干扰素生产能力的记忆样自然杀伤细胞的制备方法
CN1248919A (zh) 以细菌菌体成分为有效成分的癌症免疫治疗剂
CN1128948A (zh) 用于免疫调节和佐剂治疗的药物组合物
CN1146432C (zh) 细胞生长调节因子
CN101060851A (zh) 含有血液组分和或kDa的药剂及其用于预防和治疗免疫系统缺陷的用途
CN1249224C (zh) 超氧化物歧化酶组合物及其制备方法
CN115869340B (zh) 一种胶质瘤治疗性小胶质细胞亚群及其诱导方法
US9056070B2 (en) Autologous biological cancer vaccine
HK1086285A (en) Proteoglycan isolated from cartilaginous fish and process for producing the same
CN1785432A (zh) 一类封闭myc细胞增殖途径的染色质肽药物分子
CN101056645A (zh) 使用具有低于10000道尔顿的分子量的白细胞匀浆治疗细胞免疫性缺陷
CN112587653A (zh) Ogr1的用途
CN1850107A (zh) 一种用于恶性胸腹腔积液的脂肪乳组合物及其制备方法
CN1872333A (zh) 一种胎盘因子及其制备方法与应用
US20150140035A1 (en) Autologous biological cancer vaccine
Konsak et al. Comparison of the digestive microbiota between two divergent lines of chickens selected based on apparent metabolisable energy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication